Key Takeaways HTFL gained FDA clearance for its Next Gen Plaque Analysis platform.HTFL will see nationwide Cigna coverage for the platform starting in October.HTFL's upgrade improves plaque detection by 21% with 3D visualization.Heartflow (HTFL) has secured a dual milestone with FDA 510(k) clearance for its Next Gen Plaque Analysis platform and new nationwide coverage from Cigna, effective October. The update enhances detection accuracy by 21% compared to the prior version and offers 3D visualization of pla ...